Swiss National Bank’s Endologix Inc ELGX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q4
Sell
-13,790
Closed -$263K 2553
2018
Q3
$263K Hold
13,790
﹤0.01% 2491
2018
Q2
$781K Hold
13,790
﹤0.01% 2302
2018
Q1
$583K Hold
13,790
﹤0.01% 2326
2017
Q4
$738K Hold
13,790
﹤0.01% 2255
2017
Q3
$615K Hold
13,790
﹤0.01% 2306
2017
Q2
$670K Buy
13,790
+1,730
+14% +$102K ﹤0.01% 2301
2017
Q1
$873K Hold
12,060
﹤0.01% 2114
2016
Q4
$690K Hold
12,060
﹤0.01% 2246
2016
Q3
$1.54M Sell
12,060
-430
-3% -$55K ﹤0.01% 1681
2016
Q2
$1.56M Buy
12,490
+370
+3% +$42.5K ﹤0.01% 1683
2016
Q1
$979K Buy
12,120
+3,080
+34% +$254K ﹤0.01% 1906
2015
Q4
$895K Hold
9,040
﹤0.01% 1901
2015
Q3
$1.11M Buy
9,040
+1,030
+13% +$140K ﹤0.01% 1721
2015
Q2
$1.23M Buy
8,010
+880
+12% +$145K ﹤0.01% 1664
2015
Q1
$1.22M Hold
7,130
﹤0.01% 1648
2014
Q4
$1.09M Buy
7,130
+290
+4% +$36.2K ﹤0.01% 1676
2014
Q3
$725K Hold
6,840
﹤0.01% 1848
2014
Q2
$1.04M Buy
6,840
+260
+4% +$34.6K ﹤0.01% 1705
2014
Q1
$847K Buy
6,580
+1,460
+29% +$227K ﹤0.01% 1810
2013
Q4
$893K Hold
5,120
﹤0.01% 1603
2013
Q3
$826K Hold
5,120
﹤0.01% 1589
2013
Q2
$680K Buy
+5,120
New +$723K ﹤0.01% 1698

Other funds holding ELGX

Swiss National Bank's ELGX Position: Q4 2018 in Review

Swiss National Bank sold out of Endologix Inc (ELGX) in Q4 2018, closing a stake of 13,790 shares — an estimated $263K sold.

Swiss National Bank first reported a position in ELGX in Q2 2013 and held it in 22 quarters. The position peaked at $1.56M in Q2 2016. 99 funds tracked by Wall St. Rank hold ELGX as of Q4 2018.

  • Swiss National Bank reported no remaining Endologix Inc position as of Q4 2018 after selling out during the quarter.
  • Swiss National Bank sold 13,790 Endologix Inc shares in Q4 2018, an estimated $263K.
  • Swiss National Bank first reported a position in Endologix Inc in Q2 2013 and held it in 22 quarters.
  • Swiss National Bank's Endologix Inc position peaked at $1.56M in Q2 2016.
  • 99 funds tracked by Wall St. Rank held Endologix Inc as of Q4 2018.

Based on Swiss National Bank's 13F filing for Q4 2018, filed 13 Feb 2019.